🇺🇸 FDA
Patent

US 8030341

Dmt-derivative compounds and related compositions and methods of use

granted A61KA61K38/00

Quick answer

US patent 8030341 (Dmt-derivative compounds and related compositions and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K38/00